Midol
NDC 67751-145, ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE, tablet, from Navajo Manufacturing Company Inc..
- Product NDC
- 67751-145
- Status
- Listed
- Labeler
- Navajo Manufacturing Company Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M013
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67751-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAMINOPHEN500 mg/1
- CAFFEINE60 mg/1
- PYRILAMINE MALEATE15 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67751-145-01 | 67751014501 | 2 POUCH in 1 CARTON (67751-145-01) / 2 TABLET in 1 POUCH |
| 67751-145-02 | 67751014502 | 2 POUCH in 1 CARTON (67751-145-02) / 4 TABLET in 1 POUCH |
| 67751-145-06 | 67751014506 | 3 POUCH in 1 CARTON (67751-145-06) / 2 TABLET in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 67751-145 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67751-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67751-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.